UBS Group
APIC

UBS Group’s Apigee Corporation Common Stock APIC Stock Holding History

UBS Group’s Portfolio APIC Stock Details APIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,049
Closed -$262K – 8388
2016
Q3 		$262K Buy
15,049
+12,765
+559% +$187K ﹤0.01% 4356
2016
Q2 		$28K Sell
2,284
-371
-14% -$3.94K ﹤0.01% 6023
2016
Q1 		$22K Buy
2,655
+1,427
+116% +$10.6K ﹤0.01% 6150
2015
Q4 		$10K Buy
1,228
+29
+2% +$253 ﹤0.01% 7319
2015
Q3 		$13K Sell
1,199
-449
-27% -$3.89K ﹤0.01% 7108
2015
Q2 		$16K Buy
+1,648
New +$22.6K ﹤0.01% 7107

UBS Group's APIC Position: Q4 2016 in Review

UBS Group sold out of Apigee Corporation Common Stock (APIC) in Q4 2016, closing a stake of 15,049 shares — an estimated $262K sold.

UBS Group first reported a position in APIC in Q2 2015 and held it in 6 quarters. The position peaked at $262K in Q3 2016. 0 funds tracked by Wall St. Rank hold APIC as of Q4 2016.

  • UBS Group reported no remaining Apigee Corporation Common Stock position as of Q4 2016 after selling out during the quarter.
  • UBS Group sold 15,049 Apigee Corporation Common Stock shares in Q4 2016, an estimated $262K.
  • UBS Group first reported a position in Apigee Corporation Common Stock in Q2 2015 and held it in 6 quarters.
  • UBS Group's Apigee Corporation Common Stock position peaked at $262K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Apigee Corporation Common Stock as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.